Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
Rank in Stocks
#4607
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Share Price
$3.28
Market Cap
$3.32B
Change (1 day)
4.19%
Change (1 year)
-10.41%
Country
CN
Trade Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Category
Healthcare
Revenue for Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Revenue in Jun 2026 TTM: $886.77M
According to Jiangsu Nhwa Pharmaceutical Co., Ltd. latest financial reports the company's current revenue (TTM) is $886.77M. In 2023 the company made a revenue of $712.22M an increase over the revenue in the year 2022 that was $623.16M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Jiangsu Nhwa Pharmaceutical Co., Ltd. from 2005 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $886.77M | 13.60% |
| 2024 | $780.59M | 9.60% |
| 2023 | $712.22M | 14.29% |
| 2022 | $623.16M | 0.64% |
| 2021 | $619.21M | 20.34% |
| 2020 | $514.54M | -13.65% |
| 2019 | $595.88M | 6.24% |
| 2018 | $560.89M | 7.53% |
| 2017 | $521.61M | 20.00% |
| 2016 | $434.66M | 2.02% |
| 2015 | $426.03M | 5.50% |
| 2014 | $403.84M | 9.55% |
| 2013 | $368.64M | 15.95% |
| 2012 | $317.92M | 26.25% |
| 2011 | $251.82M | 27.80% |
| 2010 | $197.05M | 21.09% |
| 2009 | $162.72M | 16.57% |
| 2008 | $139.59M | 26.64% |
| 2007 | $110.22M | 23.66% |
| 2006 | $89.14M | 12.63% |
| 2005 | $79.14M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 645.58% |
IN
|
